Gary Acton Selected Research

Gary Acton Research Topics

7	Neoplasms (Cancer) 01/2022 - 04/2011
3	Breast Neoplasms (Breast Cancer) 03/2016 - 11/2011
2	Stomatitis 10/2016 - 09/2015
2	Neutropenia 09/2015 - 01/2015
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2018
1	Ovarian Neoplasms (Ovarian Cancer) 03/2016
1	Pneumonia (Pneumonitis) 09/2015
1	Sepsis (Septicemia) 09/2015
1	Febrile Neutropenia 09/2015
1	Thrombocytopenia (Thrombopenia) 01/2015
1	Anemia 01/2015
1	Disease Progression 11/2011
1	Chills 04/2011
1	Melanoma (Melanoma, Malignant) 04/2011
1	Headache (Headaches) 04/2011
1	Fever (Fevers) 04/2011
1	Fatigue 04/2011
1	Renal Cell Carcinoma (Grawitz Tumor) 04/2011
1	Vomiting 04/2011

4	Pharmaceutical PreparationsIBA 10/2016 - 04/2011
2	vosaroxinIBA 11/2018 - 09/2015
2	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2018 - 09/2015
2	rucaparibIBA 03/2016 - 01/2016
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 03/2016 - 01/2016
1	N- (1- (7- fluoro- 2- (pyridin- 2- yl)quinolin- 3- yl)ethyl)- 9H- purin- 6- amineIBA 01/2022
1	vecabrutinibIBA 01/2022
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019
1	EnzymesIBA 10/2016
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 03/2016
1	PlatinumIBA 03/2016
1	1- cyclopropyl- 3- (3- (5- morpholin- 4- ylmethyl- 1H- benzoimidazol- 2- yl)- 1H- pyrazol- 4- yl)ureaIBA 01/2015
1	Aurora Kinase AIBA 01/2015
1	Aurora KinasesIBA 01/2015
1	Estrogen ReceptorsIBA 11/2011
1	Estrogens (Estrogen)FDA Link 11/2011
1	Letrozole (Femara)FDA LinkGeneric 11/2011
1	AntigensIBA 11/2011
1	epitumomabIBA 11/2011
1	Hormones (Hormone)IBA 11/2011
1	Immunoglobulins (Immunoglobulin)IBA 11/2011
1	Biomarkers (Surrogate Marker)IBA 04/2011
1	CytokinesIBA 04/2011
1	Interleukin-12 (IL 12)IBA 04/2011
1	Transaminases (Aminotransferases)IBA 04/2011
1	InterferonsIBA 04/2011
1	Fibronectins (Fibronectin)IBA 04/2011
1	Proteins (Proteins, Gene)FDA Link 04/2011